Article ID Journal Published Year Pages File Type
5825796 Clinical Therapeutics 2012 8 Pages PDF
Abstract
LPA genotyping in the context of the aspirin use guidelines for primary prevention of CVD could be cost-effective.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease
Authors
, , , , ,